IFN therapy is one of the few approaches found to improve the survival of pancreatic cancer patients, and the addition of an IFN-expressing OAd may leads us a step further in the development of an effective multimodal treatment against this disease. The gene discussed is IFNA1; the disease is familial pancreatic carcinoma.